Genome Profiling of Chronic Myelomonocytic Leukemia
Author Information
Author(s): Gelsi-Boyer Véronique, Trouplin Virginie, Adélaïde José, Aceto Nicola, Remy Virginie, Pinson Stephane, Houdayer Claude, Arnoulet Christine, Sainty Danielle, Bentires-Alj Mohamed, Olschwang Sylviane, Vey Norbert, Mozziconacci Marie-Joëlle, Birnbaum Daniel, Chaffanet Max
Primary Institution: Centre de Recherche en Cancérologie de Marseille
Hypothesis
What are the genetic alterations present in chronic myelomonocytic leukemia (CMML)?
Conclusion
The study found frequent RAS pathway mutations and RUNX1 alterations in CMML, including a novel USP16-RUNX1 fusion.
Supporting Evidence
- Two-thirds of samples did not show any obvious alteration of aCGH profiles.
- RAS mutations were detected in 4 cases, including a rare mutation in KRAS.
- RUNX1 alterations included 9 mutations and 2 rearrangements.
- The study identified a new cryptic inversion leading to a USP16-RUNX1 fusion.
Takeaway
Researchers looked at the genes in patients with a type of blood cancer called CMML and found some important changes in their DNA that could help understand the disease better.
Methodology
The study used high-density array-comparative genomic hybridization (aCGH) and sequencing of 12 candidate genes on 30 CMML samples from 29 patients.
Potential Biases
Potential biases may arise from the selection of samples and the retrospective nature of the study.
Limitations
The study may not capture all genetic alterations due to the limitations of aCGH and the small sample size.
Participant Demographics
The study included 30 samples from 29 patients, with a mix of newly diagnosed and previously treated individuals.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website